The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media ...

As the buzz around GLP-1 medications grew to a fever pitch over the past two years, many digital health and telehealth ...

Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to approve an oral version of its anti-obesity medication, moving ahead in ...

Scientists discovered that people taking weight loss medications regained pounds weeks after they stopped taking the drugs. More than 1,000 people participated in a study and their lifestyle habits ...

Novo Nordisk has reduced the prices of Wegovy by 37%. The obesity pen's lowest dose of 0.25 mg will sell at Rs 10,850 for a ...

The Combating Counterfeit Pharmaceuticals Act, which would amend the Fentanyl Sanctions Act, is authored by Sens. Tom Cotton ...

"Given the escalating obesity rates, especially severe obesity among women, and the growing popularity of anti-obesity medications, exploring the association between anti-obesity medication and ...

WASHINGTON—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed ...

Conversations between the patient and provider should focus on the stakes of antiobesity treatment and continuation, says Hamlet Gasoyan, PhD, Cleveland Clinic. Hamlet Gasoyan, PhD, researcher at the ...